Avril Biopharma, Inc. uses novel bioinformatics and recombinant gene technologies to design, build and manufacture next-generation molecular medicines. Our mission is to transform the speed, safety and economy with which new products can be brought to the clinic. Our Structural Genetics ™ bioinformatics and AdCEV ™ /Egg protein expression platform are integrated to improve discovery, molecular engineering, product testing, scaling and deployment-- for one person or for millions. We offer our services to help address two industry challenges: 1. Rapid design, development and production of vaccines, therapeutics, biosimilars & diagnostics for global health and emerging disease threats and; 2. Customized drugs for personalized medicine and gene therapy (anti-cancer vaccines, gene-therapy drugs). We are building an end-to-end platform for rapid, rational development of emergency vaccines, on-demand personalized medicines and other therapeutic and diagnostic products.